✦ LIBER ✦

PARP inhibition in BRCA-mutated breast and ovarian cancers

✍ Scribed by Stephen L Chan; Tony Mok

Book ID: 117307041
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 336 KB
Volume: 376
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(10)61119-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PARP Inhibitors in BRCA Gene-Mutated Ova

PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond

✍ Susana Banerjee; Stan Kaye 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 196 KB

BRCA2 mutations in primary breast and ov

BRCA2 mutations in primary breast and ovarian cancers

✍ Lancaster, Johnathan M.; Wooster, Richard; Mangion, Jonathon; Phelan, Catherine 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 378 KB

BRCA1 and BRCA2 mutations in breast/ovar

BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy

✍ L. Stuppia; P. Di Fulvio; G. Aceto; S. Pintor; S. Veschi; V. Gatta; A. Colosimo; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

We report on the screening of the entire BRCA1/BRCA2 coding sequence by SSCP, PTT, and direct sequencing in 68 Italian families with recurrent breast or ovarian cancer. For each investigated proband, the probability of being carrier of a BRCA1/BRCA2 mutation was evaluated using the BRCAPRO software.

BRCA1 mutation analysis in 83 Spanish br

BRCA1 mutation analysis in 83 Spanish breast and breast/ovarian cancer families

✍ Orland Díez; Joan Cortés; Montserrat Domènech; Joan Brunet; Elisabeth Del Río; C 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 142 KB 👁 2 views

A group of 83 Spanish BC/OC families were analysed for BRCA1 germ-line mutations. Analysis of the entire coding sequence was carried out by SSCP and PTT. We identified 5 frameshift mutations: 185delAG (2 times), 189insTGTC, 1241delAC, and 5537delA and 3 missense mutations in BRCA1: 330A G G, 1240C G

BRCA1-related breast cancer in Austrian

✍ Teresa M. U. Wagner; Regine A. Möslinger; Daniela Muhr; Gudrun Langbauer; Kora H 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 76 KB 👁 2 views

We identified 17 BRCA1 mutations in 86 Austrian breast and ovarian cancer families (20%) that were screened for mutations by denaturing high-performance liquid chromatography (DHPLC) and the protein truncation test (PTT). Eleven distinct mutations were detected, 4 of them (962del4, 2795del4, 3135del

Prevalence of BRCA1 and BRCA2 mutations

Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

✍ Muhammad U. Rashid; Anbreen Zaidi; Diana Torres; Faisal Sultan; Axel Benner; Bil 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 312 KB 👁 2 views

## Abstract Among Asian countries, Pakistan has the highest rates of breast and ovarian cancer. To assess the contribution of the __BRCA1__ and __BRCA2__ germ line mutations to these high rates, we conducted the first study of 176 Pakistani breast and ovarian cancer patients, selected on family his